Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 110, Issue 1-2, Pages 230-239Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0165-5728(00)00315-5
Keywords
AIDS; brain; chemokine
Categories
Funding
- NIMH NIH HHS [MH55477] Funding Source: Medline
- NINDS NIH HHS [NS07098] Funding Source: Medline
Ask authors/readers for more resources
Microglia are the major target of HIV-I infection in the brain. Microglial infection is CD4-dependent, but the role of chemokine receptors CCR5 and CCR3 and their natural Ligands in modulating HIV-1 infection in microglia has been questioned. In primary human fetal microglial cultures, we demonstrate that HIV-1 infection of these cells is dependent on CCRS, since an antibody to CCRS completely blocked productive infection. Anti-CCR3, in contrast, had a smaller inhibitory effect which was not statistically significant. The chemokine ligands for CCRS, RANTES and MIP-1 beta, also potently inhibited HIV-1 infection in microglia, but the third ligand MIP-1 alpha failed to show inhibition. Interestingly, when microglial cultures were treated with antibodies specific to each of these chemokines, HIV-1 infection was enhanced by anti-RANTES and anti-MIP-1 beta, but not by anti-MIP-1 alpha. These results demonstrate the presence of endogenous chemokines that act as endogenous inhibitors of HIV-1 infection in microglia. Additionally, IFN beta, a known anti-viral cytokine, also provided potent inhibition of viral infection as well as induction of all three chemokines in microglia. These results suggest the possibility that type I interferon can down-modulate microglial HIV-1 infection in vivo by multiple mechanisms. (C) 2000 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available